The role of amino acid changes in the human immunodeficiency virus type 1 transmembrane domain in antibody binding and neutralization

被引:19
作者
Lovelace, Erica [1 ]
Xu, Hengyu
Blish, Catherine A. [1 ]
Strong, Roland
Overbaugh, Julie [1 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA
基金
比尔及梅琳达.盖茨基金会;
关键词
HIV-1; Antibody binding; Antibody neutralization; Envelope; gp41; PROXIMAL EXTERNAL REGION; HUMAN MONOCLONAL-ANTIBODIES; POINT MUTATION; GP120; GLYCOPROTEIN; ENVELOPE VARIANTS; EPITOPE EXPOSURE; HIV-1; GP41; SENSITIVITY; RESISTANCE;
D O I
10.1016/j.virol.2011.09.032
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The detailed interactions between antibodies and the HIV-1 envelope protein that lead to neutralization are not well defined. Here, we show that several conservative substitutions in the envelope gp41 led to a similar to 100 fold increase in neutralization sensitivity to monoclonal antibodies (MAbs) that target gp41: 4E10 and 2F5. Substitution at position 675 alone did not impact neutralization susceptibility to MAbs that recognize more distal sites in gp120 (b12, VRC01, PG9). However, changes at position 675 in conjunction with Thr to Ala at position 569 increased the neutralization sensitivity to all gp41 and gp120 MAbs and plasma, in some cases by more than 1000-fold. Interestingly, the T569A change had a dramatic effect on b12 binding, but no effect on neutralization sensitivity. This finding suggests that antibody neutralization may occur through a multi-step pathway that includes distinct changes in envelope conformation that may affect binding but not neutralization susceptibility. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 61 条
[1]   MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP41 AFFECT SENSITIVITY TO NEUTRALIZATION BY GP120 ANTIBODIES [J].
BACK, NKT ;
SMIT, L ;
SCHUTTEN, M ;
NARA, PL ;
TERSMETTE, M ;
GOUDSMIT, J .
JOURNAL OF VIROLOGY, 1993, 67 (11) :6897-6902
[2]   Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies [J].
Binley, JA ;
Wrin, T ;
Korber, B ;
Zwick, MB ;
Wang, M ;
Chappey, C ;
Stiegler, G ;
Kunert, R ;
Zolla-Pazner, S ;
Katinger, H ;
Petropoulos, CJ ;
Burton, DR .
JOURNAL OF VIROLOGY, 2004, 78 (23) :13232-13252
[3]   Mutations in envelope gp120 can impact proteolytic processing of the gp160 precursor and thereby affect neutralization sensitivity of human immunodeficiency virus type 1 pseudoviruses [J].
Blay, Wendy M. ;
Kasprzyk, Theresa ;
Misher, Lynda ;
Richardson, Barbra A. ;
Haigwood, Nancy L. .
JOURNAL OF VIROLOGY, 2007, 81 (23) :13037-13049
[4]   Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41 [J].
Blish, Catherine A. ;
Nguyen, Minh-An ;
Overbaugh, Julie .
PLOS MEDICINE, 2008, 5 (01) :90-103
[5]   HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry [J].
Blish, Catherine A. ;
Nedellec, Rebecca ;
Mandaliya, Kishorchandra ;
Mosier, Donald E. ;
Overbaugh, Julie .
AIDS, 2007, 21 (06) :693-702
[6]   Comparative Immunogenicity of Subtype A Human Immunodeficiency Virus Type 1 Envelope Exhibiting Differential Exposure of Conserved Neutralization Epitopes [J].
Blish, Catherine A. ;
Sather, D. Noah ;
Sellhorn, George ;
Stamatatos, Leonidas ;
Sun, Yide ;
Srivastava, Indresh ;
Barnett, Susan W. ;
Cleveland, Brad ;
Overbaugh, Julie ;
Hu, Shiu-lok .
JOURNAL OF VIROLOGY, 2010, 84 (05) :2573-2584
[7]   Cross-Subtype Neutralization Sensitivity despite Monoclonal Antibody Resistance among Early Subtype A, C, and D Envelope Variants of Human Immunodeficiency Virus Type 1 [J].
Blish, Catherine A. ;
Jalalian-Lechak, Zahra ;
Rainwater, Stephanie ;
Nguyen, Minh-An ;
Dogan, Ozge C. ;
Overbaugh, Julie .
JOURNAL OF VIROLOGY, 2009, 83 (15) :7783-7788
[8]   Antibody vs. HIV in a clash of evolutionary titans [J].
Burton, DR ;
Stanfield, RL ;
Wilson, IA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (42) :14943-14948
[9]   EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY [J].
BURTON, DR ;
PYATI, J ;
KODURI, R ;
SHARP, SJ ;
THORNTON, GB ;
PARREN, PWHI ;
SAWYER, LSW ;
HENDRY, RM ;
DUNLOP, N ;
NARA, PL ;
LAMACCHIA, M ;
GARRATTY, E ;
STIEHM, ER ;
BRYSON, YJ ;
CAO, YZ ;
MOORE, JP ;
HO, DD ;
BARBAS, CF .
SCIENCE, 1994, 266 (5187) :1024-1027
[10]   HIV vaccine design and the neutralizing antibody problem [J].
Burton, DR ;
Desrosiers, RC ;
Doms, RW ;
Koff, WC ;
Kwong, PD ;
Moore, JP ;
Nabel, GJ ;
Sodroski, J ;
Wilson, IA ;
Wyatt, RT .
NATURE IMMUNOLOGY, 2004, 5 (03) :233-236